Literature DB >> 23380750

Noninvasive assessment of right heart function and hemodynamics during exercise in patients with pulmonary arterial hypertension.

Michelle L Freeman1, Carolyn Landolfo, Robert E Safford, Cesar A Keller, Michael G Heckman, Charles D Burger.   

Abstract

OBJECTIVES: Noninvasive assessment of right heart function and hemodynamics in patients with pulmonary arterial hypertension (PAH) is most often performed at rest, whereas the symptoms, in general, present with exertion. Assessment during exertion is limited to symptom assessment and the 6-minute walk distance. We investigated the feasibility of obtaining echocardiographic data that could accurately reflect pulmonary artery pressures (PAP), particularly mean PAP and right ventricular function during exercise in patients with PAH.
METHODS: We investigated right ventricular function and hemodynamics using echocardiography during symptom-limited exercise in 10 consecutive patients undergoing right heart catheterization (RHC) as part of their clinical evaluation for PAH. We further assessed these measurements for correlation with known predictors of outcome in PAH in an exploratory analysis.
RESULTS: We were able to successfully obtain complete right heart measurements by echocardiography, including mean PAP, in the majority (9 of 10) of the subjects. One patient had an incomplete tricuspid regurgitation jet at rest and with exercise. Echocardiographic pulmonary vascular resistance correlated with RHC cardiac output and brain natriuretic peptide level, whereas tricuspid annular plane systolic excursion during exercise correlated with right atrial pressure on RHC, brain natriuretic peptide, and 6-minute walk distance. Tricuspid regurgitation velocity and mean PAP with exercise correlated moderately with mean PAP and cardiac output by RHC.
CONCLUSIONS: Exercise echocardiography can provide meaningful data in patients with PAH, including measuring mean PAP. The presence of correlations in this small number of patients indicates promising targets for future investigation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23380750      PMCID: PMC3626433          DOI: 10.1097/SMJ.0b013e3182805165

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  17 in total

Review 1.  Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.

Authors:  Vallerie V McLaughlin; Kenneth W Presberg; Ramona L Doyle; Steven H Abman; Douglas C McCrory; Terry Fortin; Gregory Ahearn
Journal:  Chest       Date:  2004-07       Impact factor: 9.410

2.  Cardiopulmonary exercise testing and six-minute walk correlations in pulmonary arterial hypertension.

Authors:  Ronald J Oudiz; Robyn J Barst; James E Hansen; Xing-Guo Sun; Robert Garofano; Xionghua Wu; Karlman Wasserman
Journal:  Am J Cardiol       Date:  2005-11-10       Impact factor: 2.778

3.  Exercise stress echocardiography of the pulmonary circulation: limits of normal and sex differences.

Authors:  Paola Argiento; Rebecca R Vanderpool; Massimiliano Mulè; Maria Giovanna Russo; Michele D'Alto; Eduardo Bossone; Naomi C Chesler; Robert Naeije
Journal:  Chest       Date:  2012-11       Impact factor: 9.410

4.  American Society of Echocardiography recommendations for performance, interpretation, and application of stress echocardiography.

Authors:  Patricia A Pellikka; Sherif F Nagueh; Abdou A Elhendy; Cathryn A Kuehl; Stephen G Sawada
Journal:  J Am Soc Echocardiogr       Date:  2007-09       Impact factor: 5.251

5.  Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines.

Authors:  David B Badesch; Steven H Abman; Gerald Simonneau; Lewis J Rubin; Vallerie V McLaughlin
Journal:  Chest       Date:  2007-06       Impact factor: 9.410

6.  The noninvasive evaluation of exercise-induced changes in pulmonary artery pressure and pulmonary vascular resistance.

Authors:  Chad M Bidart; Amr E Abbas; James M Parish; Hari P Chaliki; Carlos A Moreno; Steven J Lester
Journal:  J Am Soc Echocardiogr       Date:  2007-03       Impact factor: 5.251

7.  The 6-min walk test (6MW) as an efficacy endpoint in pulmonary arterial hypertension clinical trials: demonstration of a ceiling effect.

Authors:  Adaani E Frost; D Langleben; R Oudiz; N Hill; E Horn; V McLaughlin; I M Robbins; S Shapiro; V F Tapson; D Zwicke; T DeMarco; R Schilz; M Rubenfire; R J Barst
Journal:  Vascul Pharmacol       Date:  2005-06       Impact factor: 5.773

Review 8.  Exercise in patients with pulmonary arterial hypertension.

Authors:  Smita A Desai; Richard N Channick
Journal:  J Cardiopulm Rehabil Prev       Date:  2008 Jan-Feb       Impact factor: 2.081

9.  Exercise Doppler echocardiography identifies preclinic asymptomatic pulmonary hypertension in systemic sclerosis.

Authors:  Alberto Pignone; Fabio Mori; Francesco Pieri; Andrea Oddo; Gianna Galeota; Ginevra Fiori; Angela Del Rosso; Federico Perfetto; Aureliano Becucci; Riccardo Livi; Alessio Tempestini; Chiara Benvenuti; Leonardo Gramigna; Roberto Fedi; Sergio Generini; Martina Minelli; Marina Cinelli; Serena Guiducci; Chiara Arcangeli; Maria Letizia Conforti; Pasquale Bernardo; Marco Matucci Cerinic
Journal:  Ann N Y Acad Sci       Date:  2007-06       Impact factor: 5.691

10.  A simple method for noninvasive estimation of pulmonary vascular resistance.

Authors:  Amr E Abbas; F David Fortuin; Nelson B Schiller; Christopher P Appleton; Carlos A Moreno; Steven J Lester
Journal:  J Am Coll Cardiol       Date:  2003-03-19       Impact factor: 24.094

View more
  1 in total

1.  Accuracy of Echocardiography to Estimate Pulmonary Artery Pressures With Exercise: A Simultaneous Invasive-Noninvasive Comparison.

Authors:  Annelieke C M J van Riel; Alexander R Opotowsky; Mário Santos; Jose M Rivero; Andy Dhimitri; Barbara J M Mulder; Berto J Bouma; Michael J Landzberg; Aaron B Waxman; David M Systrom; Amil M Shah
Journal:  Circ Cardiovasc Imaging       Date:  2017-04       Impact factor: 7.792

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.